Chodak on Urology

• Screening Decision Aids No Substitute for Patient-Doc Discussion   When it comes to prostate cancer screening, decision aids cannot replace a conversation between a man and his physician.
  Medscape Urology, September 09, 2019
• Testosterone May Be Safe After Prostate Cancer Treatment   Studies show similar survival in men who used testosterone after radical prostatectomy or radiation therapy compared with those who did not.
  Medscape Urology, August 13, 2019
• Prostate Cancer Diagnoses Delayed With 5-ARIs   Physicians need to be aware that PSA levels may be 50% lower in men taking these drugs, causing a delay in diagnosis, says Dr Chodak.
  Medscape Urology, July 09, 2019
• Study Finds Little Benefit From Most Nutritional Supplements   Why do people continue to take dietary supplements when study after study finds little benefit?
  Medscape Urology, May 23, 2019
• Fingerprick PSA Test: Clear Benefits, but Also a Few Concerns   Dr Gerald Chodak discusses what we know and what we still need to learn about the Sangia Total PSA Test.
  Medscape Urology, May 06, 2019
• Race and PSA Impact Mortality in Low-Risk Prostate Cancer   Dr Gerald Chodak discusses recent findings suggesting that race does not affect mortality risk when PSA levels are below 4 ng/mL.
  Medscape Urology, April 16, 2019
• Final LATITUDE Data Confirm Abiraterone's Long-term OS Benefits   Dr Gerald Chodak discusses the benefits of a more potent antiandrogen for men with high-risk, hormone-naive, metastatic prostate cancer.
  Medscape Urology, April 02, 2019
• Can Vitamin D Supplementation Reduce Cancer or CVD Risk?   Gerald Chodak discusses new data on omega-3 fatty acid and vitamin D supplementation, and the risk for cancer and cardiovascular disease.
  Medscape Urology, February 27, 2019
• Are There Health Consequences of Declining Sperm Counts?   Gerald Chodak discusses results from a meta-analysis of sperm counts and concentration among more than 40,000 men.
  Medscape Urology, February 11, 2019
• Enzalutamide + ADT Delays Metastatic Prostate Cancer Progression   Dr Gerald Chodak reviews early results of the ARCHES study looking at the combination of ADT with the antiandrogen enzalutamide.
  Medscape Urology, January 24, 2019
• Is Local Radiation Beneficial in Metastatic Prostate Cancer?   Gerald Chodak discusses recent findings from the STAMPEDE trial on the benefit of local radiation therapy for metastatic prostate cancer.
  Medscape Urology, December 20, 2018
• A Three-Pronged Attack on Recurring Prostate Cancer   Results from the SPPORT trial seem hopeful, but are they good enough to adopt across the board?
  Medscape Urology, November 29, 2018
• Correcting Patients' Understanding of Alternative Cancer Therapies   Dr Gerald Chodak discusses results from the ASCO National Cancer Opinion Survey.
  Medscape Urology, November 27, 2018
• Does ADT + Radiation Improve Survival in Metastatic Disease?   A new study underscores the value of RCTs when making treatment decisions.
  Medscape Urology, November 13, 2018
• Does Prostate Cancer Screening Decrease Mortality?   Dr Gerald Chodak discusses recent findings from a retrospective analysis on the magnitude of benefit with prostate cancer screening.
  Medscape Urology, October 16, 2018
• Does Active Surveillance Increase Risks in Younger Men?   A new meta-analysis compares disease progression in younger versus older men on active surveillance.
  Medscape Urology, October 04, 2018
• Have Relaxed PSA Recs Resulted in Unchecked Prostate Cancer?   Are patients being diagnosed with more advanced prostate cancer now that PSA screening recommendations have changed? Dr Chodak reviews a study seeking to answer this question.
  Medscape Urology, September 20, 2018
• Should Focal Therapy Be Used in Localized Prostate Cancer?   Should high-intensity focused ultrasound be used in men with localized prostate cancer? Dr Gerald Chodak discusses recent data on this topic.
  Medscape Urology, August 21, 2018
• 18-Year Follow-up Data Vindicate Finasteride   Dr Gerald Chodak discusses a long-term study demonstrating the efficacy of finasteride in preventing prostate cancer, as well as the questions it raises regarding clinical use.
  Medscape Urology, August 14, 2018
• When Is Active Surveillance for Prostate Cancer Safe?   The ASCO Post convened an expert panel to answer questions about active surveillance of prostate cancer. Unfortunately, more questions remain, says Dr Chodak.
  Medscape Urology, August 10, 2018